Provided By GlobeNewswire
Last update: Aug 7, 2025
Q2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024;
Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024;
BIODESIX INC
NASDAQ:BDSX (8/22/2025, 8:00:02 PM)
0.4534
+0.03 (+6.98%)
Find more stocks in the Stock Screener